New filler faces off against market leader in cheek volume study
NCT ID NCT07162610
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 34 times
Summary
This study tests whether a new dermal filler (Rejuviel V with lidocaine) works as well as an approved one (JUVEDERM VOLUMA with lidocaine) for temporarily adding volume to the mid-face area, like the cheeks. About 89 Korean adults aged 30-65 with moderate to severe volume loss will receive injections and be followed for up to 48 weeks. The goal is to see if the new filler is safe and effective for cosmetic improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MID FACE VOLUME DEFICIT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chung-Ang University Hospital
Soeul, South Korea
Conditions
Explore the condition pages connected to this study.